The world of sequence variation IP is complicated and confusing, and fraught with legal risk, but there is a solution, as Ellen Sherin of GQ Life Sciences reports. The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021, up from $172.5 billion in 2016, rising at a compound annual growth…

Read More

We are again excited to welcome thought leader Dr. Stephen Tedeschi as a guest blogger. Dr. Tedeschi, is a Partner at PatentVantage, a leading patent research and strategy firm. He is also an Adjunct Faculty member at the National Institute of Health’s Foundation for Advanced Education in the Sciences (FAES). For more on Dr. Tedeschi,…

Read More

We are excited to welcome thought leader Dr. Stephen Tedeschi as a guest blogger. Dr. Tedeschi, is a Partner at PatentVantage, a leading patent research and strategy firm. He is also an Adjunct Faculty member at the National Institute of Health’s Foundation for Advanced Education in the Sciences (FAES). For more on Dr. Tedeschi, please…

Read More

I’m going to let you in on a little secret: there’s a reason why we are the market leader in patent sequence search. It has surprisingly little to do with our user-friendly search interface, our stellar customer support, or our good looks. While (at least some of) these things certainly help, it is the content…

Read More

When you work with DNA or protein sequences, inevitably, you’re going to run into the challenge of finding similar biological sequences that have been listed in patents. In most cases, you’re likely to know specific mutations at specific positions that you want to search for. The challenge is, how do you define a query that…

Read More

Because GenomeQuest’s GQ-Pat is a document database rather than a family database, you might hit the same sequence more than once because it occurs in document A and document B both in the same family. That’s actually incredibly useful because it allows you to examine how sequences found in patents change from patent family member…

Read More